• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道疾病中SARC-F评分与控制营养状况评分之间的关系

The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases.

作者信息

Ikegami Takako, Nishikawa Hiroki, Goto Masahiro, Matsui Masahiro, Asai Akira, Ushiro Kosuke, Ogura Takeshi, Takeuchi Toshihisa, Nakamura Shiro, Kakimoto Kazuki, Miyazaki Takako, Fukunishi Shinya, Ohama Hideko, Yokohama Keisuke, Yasuoka Hidetaka, Higuchi Kazuhide

机构信息

The Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan.

The Premier Departmental Research of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan.

出版信息

J Clin Med. 2022 Jan 24;11(3):582. doi: 10.3390/jcm11030582.

DOI:10.3390/jcm11030582
PMID:35160034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8836691/
Abstract

We sought to examine the relationship between the SARC-F score and the Controlling Nutritional Status (CONUT) score in patients with gastrointestinal diseases (GDs, = 735, median age = 71 years, and 188 advanced cancer cases). The SARC-F score ≥ 4 (highly suspicious of sarcopenia) was found in 93 cases (12.7%). Mild malnutritional condition was seen in 310 cases (42.2%), moderate in 127 (17.3%) and severe in 27 (3.7%). The median SARC-F scores in categories of normal, mild, moderate and severe malnutritional condition were 0, 0, 1 and 1 (overall < 0.0001). The percentage of SARC-F score ≥ 4 in categories of normal, mild, moderate and severe malnutritional condition were 4.4%, 12.9%, 26.8% and 25.9% (overall < 0.0001). The SARC-F score was an independent factor for both the CONUT score ≥ 2 (mild, moderate or severe malnutrition) and ≥5 (moderate or severe malnutrition). In the receiver operating characteristic (ROC) curve analysis for the CONUT score ≥ 2, C reactive protein (CRP) had the highest area under the ROC (AUC = 0.70), followed by the SARC-F score (AUC = 0.60). In the ROC analysis for the CONUT score ≥ 5, CRP had the highest AUC (AUC = 0.79), followed by the SARC-F score (AUC = 0.63). In conclusion, the SARC-F score in patients with GDs can reflect malnutritional status.

摘要

我们试图研究胃肠道疾病(GDs,n = 735,中位年龄 = 71岁,其中188例为晚期癌症病例)患者的SARC - F评分与控制营养状况(CONUT)评分之间的关系。93例(12.7%)患者的SARC - F评分≥4(高度怀疑肌肉减少症)。310例(42.2%)患者存在轻度营养不良状况,127例(17.3%)为中度,27例(3.7%)为重度。正常、轻度、中度和重度营养不良状况分类中的SARC - F评分中位数分别为0、0、1和1(总体P < 0.0001)。正常、轻度、中度和重度营养不良状况分类中SARC - F评分≥4的百分比分别为4.4%、12.9%、26.8%和25.9%(总体P < 0.0001)。SARC - F评分是CONUT评分≥2(轻度、中度或重度营养不良)和≥5(中度或重度营养不良)的独立因素。在针对CONUT评分≥2的受试者工作特征(ROC)曲线分析中,C反应蛋白(CRP)的ROC曲线下面积(AUC)最高(AUC = 0.70),其次是SARC - F评分(AUC = 0.60)。在针对CONUT评分≥5的ROC分析中,CRP的AUC最高(AUC = 0.79),其次是SARC - F评分(AUC = 0.63)。总之,GDs患者的SARC - F评分可反映营养不良状况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/ff2b3dff6f88/jcm-11-00582-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/1f443e67bdc1/jcm-11-00582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/1c389c7895d2/jcm-11-00582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/ab007460b7d5/jcm-11-00582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/014d8c184ee7/jcm-11-00582-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/b5d55f7a1bd9/jcm-11-00582-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/97465e728279/jcm-11-00582-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/dffd27ed8728/jcm-11-00582-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/ff2b3dff6f88/jcm-11-00582-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/1f443e67bdc1/jcm-11-00582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/1c389c7895d2/jcm-11-00582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/ab007460b7d5/jcm-11-00582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/014d8c184ee7/jcm-11-00582-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/b5d55f7a1bd9/jcm-11-00582-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/97465e728279/jcm-11-00582-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/dffd27ed8728/jcm-11-00582-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/157b/8836691/ff2b3dff6f88/jcm-11-00582-g008.jpg

相似文献

1
The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases.胃肠道疾病中SARC-F评分与控制营养状况评分之间的关系
J Clin Med. 2022 Jan 24;11(3):582. doi: 10.3390/jcm11030582.
2
Comparison of SARC-F Score among Gastrointestinal Diseases.胃肠道疾病中SARC-F评分的比较
J Clin Med. 2021 Sep 10;10(18):4099. doi: 10.3390/jcm10184099.
3
Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients.CONUT 评分对晚期尿路上皮癌患者的预后意义。
Urol Oncol. 2020 Mar;38(3):76.e11-76.e17. doi: 10.1016/j.urolonc.2019.10.014. Epub 2019 Dec 19.
4
Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers.SARC-F评分对胃肠道晚期癌症的预后影响
Cancers (Basel). 2021 Dec 21;14(1):10. doi: 10.3390/cancers14010010.
5
Validity of the SARC-F questionnaire in assessing sarcopenia in patients with chronic kidney disease: a cross-sectional study.SARC-F问卷在评估慢性肾脏病患者肌肉减少症中的有效性:一项横断面研究。
Front Med (Lausanne). 2023 Jul 18;10:1188971. doi: 10.3389/fmed.2023.1188971. eCollection 2023.
6
Accurate SARC-F Score in Patients with Liver Disease.肝病患者准确的SARC-F评分
Diagnostics (Basel). 2023 Jun 4;13(11):1959. doi: 10.3390/diagnostics13111959.
7
Relationships between Pre-Stroke SARC-F Scores, Disability, and Risk of Malnutrition and Functional Outcomes after Stroke-A Prospective Cohort Study.卒中前 SARC-F 评分、残疾、营养不良风险与卒中后功能结局的关系:一项前瞻性队列研究。
Nutrients. 2021 Oct 13;13(10):3586. doi: 10.3390/nu13103586.
8
Comparing SARC-F with SARC-CalF for screening sarcopenia in advanced cancer patients.比较 SARC-F 与 SARC-CalF 在晚期癌症患者中筛查肌肉减少症的应用。
Clin Nutr. 2020 Nov;39(11):3337-3345. doi: 10.1016/j.clnu.2020.02.020. Epub 2020 Feb 22.
9
The prognostic impact of malnutrition in patients with severely decompensated acute heart failure, as assessed using the Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score.使用预后营养指数(PNI)和控制营养状况(CONUT)评分评估营养不良对严重失代偿性急性心力衰竭患者的预后影响。
Heart Vessels. 2018 Feb;33(2):134-144. doi: 10.1007/s00380-017-1034-z. Epub 2017 Aug 12.
10
The Relevance in the Neutrophil to Lymphocyte Ratio and the SARC-F Score in Gastrointestinal Diseases.中性粒细胞与淋巴细胞比值及SARC - F评分在胃肠道疾病中的相关性
J Clin Med. 2022 Apr 3;11(7):2012. doi: 10.3390/jcm11072012.

引用本文的文献

1
Prognostic Nutritional Index Correlates with Liver Function and Prognosis in Chronic Liver Disease Patients.预后营养指数与慢性肝病患者的肝功能及预后相关。
Diagnostics (Basel). 2023 Dec 25;14(1):49. doi: 10.3390/diagnostics14010049.
2
Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma.治疗前骨骼肌指数和 CONUT 评分对弥漫性大 B 细胞淋巴瘤的预后影响。
BMC Cancer. 2023 Nov 6;23(1):1071. doi: 10.1186/s12885-023-11590-y.
3
Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review.

本文引用的文献

1
Cancer Cachexia: Its Mechanism and Clinical Significance.癌症恶病质:发病机制及临床意义。
Int J Mol Sci. 2021 Aug 6;22(16):8491. doi: 10.3390/ijms22168491.
2
Evidence-based clinical practice guidelines for liver cirrhosis 2020.《2020年肝硬化循证临床实践指南》
Hepatol Res. 2021 Jul;51(7):725-749. doi: 10.1111/hepr.13678. Epub 2021 Jul 6.
3
Pathophysiology and mechanisms of primary sarcopenia (Review).原发性肌肉减少症的病理生理学及机制(综述)
血浆白蛋白在预后指标中的作用解读:文献综述
J Clin Med. 2023 Sep 22;12(19):6132. doi: 10.3390/jcm12196132.
4
Accurate SARC-F Score in Patients with Liver Disease.肝病患者准确的SARC-F评分
Diagnostics (Basel). 2023 Jun 4;13(11):1959. doi: 10.3390/diagnostics13111959.
5
The Geriatric Nutritional Risk Index predicts sarcopenia in patients with cirrhosis.老年营养风险指数可预测肝硬化患者的肌肉减少症。
Sci Rep. 2023 Mar 8;13(1):3888. doi: 10.1038/s41598-023-31065-1.
6
The Relevance in the Neutrophil to Lymphocyte Ratio and the SARC-F Score in Gastrointestinal Diseases.中性粒细胞与淋巴细胞比值及SARC - F评分在胃肠道疾病中的相关性
J Clin Med. 2022 Apr 3;11(7):2012. doi: 10.3390/jcm11072012.
Int J Mol Med. 2021 Aug;48(2). doi: 10.3892/ijmm.2021.4989. Epub 2021 Jun 29.
4
Reliability and Concurrent Validity of the SARC-F and Its Modified Versions: A Systematic Review and Meta-Analysis.SARC-F 及其修订版的可靠性和同时效度的系统评价和荟萃分析。
J Am Med Dir Assoc. 2021 Sep;22(9):1864-1876.e16. doi: 10.1016/j.jamda.2021.05.011. Epub 2021 Jun 16.
5
Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?CONUT 评分是否是弥漫大 B 细胞淋巴瘤患者的预后指标?
Turk J Med Sci. 2021 Aug 30;51(4):2112-2119. doi: 10.3906/sag-2101-406.
6
Approaches to Nutritional Screening in Patients with Coronavirus Disease 2019 (COVID-19).新型冠状病毒肺炎(COVID-19)患者的营养筛查方法。
Int J Environ Res Public Health. 2021 Mar 9;18(5):2772. doi: 10.3390/ijerph18052772.
7
Sarcopenia as a predictor of postoperative risk of complications, mortality and length of stay following gastrointestinal oncological surgery.肌肉减少症是胃肠道肿瘤手术后并发症、死亡率和住院时间的预测指标。
Ann R Coll Surg Engl. 2021 Oct;103(9):630-637. doi: 10.1308/rcsann.2021.0082. Epub 2021 Mar 19.
8
Cachexia, a Systemic Disease beyond Muscle Atrophy.恶病质,一种超越肌肉萎缩的全身性疾病。
Int J Mol Sci. 2020 Nov 14;21(22):8592. doi: 10.3390/ijms21228592.
9
Cachexia, muscle wasting, and frailty in cardiovascular disease.心血管疾病中的恶病质、肌肉减少症和衰弱。
Eur J Heart Fail. 2020 Dec;22(12):2314-2326. doi: 10.1002/ejhf.2011. Epub 2020 Oct 14.
10
Prognostic Potential of the Preoperative Controlling Nutritional Status (CONUT) Score in Predicting Survival of Patients with Cancer: A Systematic Review.术前控制营养状况(CONUT)评分对预测癌症患者生存预后的价值:一项系统评价。
Adv Nutr. 2021 Feb 1;12(1):234-250. doi: 10.1093/advances/nmaa102.